1 jan 2014 ano - FDA approves two immunotherapies for melanoma
Descrição:
FDA grants accelerated approval to pembrolizumab and nivilumab for patients with advanced melanoma that can no longer be removed by surgery.
Adicionado na linha do tempo:
Cancer Dates
Data:
